Phase 3b Trial To Evaluate Safety And Immune Response (Superiority) of a Two-Dose Butantan-DV Regimen And The Standard Single Dose In Dengue-Naive Children/Adolescents and Immune Response (Non-inferiority) in a Manufacturing Facility Change (DEN-06-IB)
Clinical trial NCT07712926 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07712926
- Sponsor
- Butantan Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2027-02-01
- Primary completion
- 2028-02-28
- Enrollment
- 1765
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.